BA
DVAX

Boston Advisors’s Dynavax Technologies DVAX Stock Holding History

Boston Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,330
Closed -$180K – 683
2016
Q2 		$180K Buy
12,330
+155
+1% +$2.65K ﹤0.01% 662
2016
Q1 		$234K Hold
12,175
– – 0.01% 625
2015
Q4 		$294K Buy
+12,175
New +$305K 0.01% 582

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Advisors's DVAX Position: Q3 2016 in Review

Boston Advisors sold out of Dynavax Technologies (DVAX) in Q3 2016, closing a stake of 12,330 shares — an estimated $180K sold.

Boston Advisors first reported a position in DVAX in Q4 2015 and held it in 3 quarters. The position peaked at $294K in Q4 2015. 122 funds tracked by Wall St. Rank hold DVAX as of Q3 2016.

  • Boston Advisors reported no remaining Dynavax Technologies position as of Q3 2016 after selling out during the quarter.
  • Boston Advisors sold 12,330 Dynavax Technologies shares in Q3 2016, an estimated $180K.
  • Boston Advisors first reported a position in Dynavax Technologies in Q4 2015 and held it in 3 quarters.
  • Boston Advisors's Dynavax Technologies position peaked at $294K in Q4 2015.
  • 122 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2016.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.